ShEEP Request for High-throughput Single Cell Genomics Instrumentation
ShEEP 请求高通量单细胞基因组学仪器
基本信息
- 批准号:9795153
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-01-01 至 2019-09-30
- 项目状态:已结题
- 来源:
- 关键词:AwardBiological ProcessBiopsyCell LineCellsCollaborationsContract ServicesDNADNA SequenceDevelopmentDiseaseDisease ProgressionEpigenetic ProcessEquipmentEvolutionFee-for-Service PlansFunctional disorderFundingFutureGene ExpressionGenetic TranscriptionGenomicsHeart failureHigh-Throughput Nucleotide SequencingHuman ResourcesHypertensionIndividualInvestigationKidney DiseasesLiquid substanceLocationMalignant NeoplasmsMedical centerMicrofluidic MicrochipsMicrofluidicsMinorMissionOncogenicPathogenicityPopulationPreparationProcessProgram EvaluationRNAReactionResearchResearch PersonnelResearch SupportRunningSNP genotypingSamplingSecondary toStressSystemTechnical ExpertiseTechnologyTimeTissue SampleTrainingTraumatic Brain InjuryUniversitiesVariantVeteransbasecDNA Expressioncostdesigndigitaldisease mechanisms studyepigenomicshigh throughput analysisinsightinstrumentinstrumentationmedical schoolsnext generation sequencingsingle cell analysistranscriptomicstumor
项目摘要
In this Veterans Affairs ORD Shared Equipment Evaluation Program (ShEEP) application, we are
requesting instrumentation for high throughput single-cell genomics (Fluidigm C1 Single-Cell Auto Prep
System, BioMark, and Illumina NextSeq 550 Sequencing System) to evaluate cell-specific genomic,
epigenetic, and transcriptomic variations in diseases of high relevance to the VA mission. This instrumentation
will dramatically enhance Veterans Affairs (VA) and non-VA investigators to investigate mechanisms of
disease progression at the level of single cells. Although dramatic advances have been made in the last
decade in our ability to process and sequence DNA and RNA in bulk populations of cells, until recently our
understanding of significant variations in genomic and transcriptomic information at the level of the single cell
has been limited. For instance, major insights into fundamental biological processes such as normal
development and tumor evolution secondary to oncogenic potential of single cells can only be garnered from a
detailed understanding of genomic, epigenomic, and transcriptional variation at the single-cell level. In addition,
certain pathogenic cells are so rare that single-cell approaches become essential to their identification and
characterization.
Our Genomics Core is part of an ongoing collaboration to enhance the academic and administrative
ties between the Northport Veterans Affairs Medical Center (NVAMC) and its affiliated Stony Brook University
School of Medicine (SBUSM). This new instrumentation will be housed in NVAMC and this strategic location
allows easy access to the instruments for both VA and SBUSM investigators. The location of this Core will
encourage further collaboration between VA investigators at Northport and their University colleagues at Stony
Brook. Technical support is available through the Genomics Core on a fee-for-service basis to support both VA
researchers and their collaborators. In addition, we have assembled a team of experts for bioinfomatics
support. Many of the VA investigators including Drs. Mallipattu, Lin, McKinnon, Rohatgi, Miller, Arvanian, Del
Poeta, and Obeid, whose research are supported by Merit Review Awards, and would significantly benefit from
the acquisition and utilization of this instrumentation for high throughput single-cell genomics. Trained
personnel in the Core can operate the instrument and provide technical support and we have outlined a plan to
purchase service contracts to maintain the instrument.
In this ShEEP application for high-throughput single cell genomics instrumentation, we also describe in
detail the specifics of the instrumentation, justification of need, demonstrate the technical expertise to support
the usage of the equipment, descriptions of the major and minor users, and the organizational plan for the
utilization of the instrumentation. The long-term impact of this single-cell analysis instrumentation is that it will
enhance the impact and further our currently funded VA Merit Review Awards. In addition, results acquired
from single-cell genomics will generate new hypothesis and provide new avenues for future investigations in
diseases that are highly relevant to the VA mission.
在这个退伍军人事务部ORD共享设备评估计划(ShEEP)的应用程序,我们是
要求高通量单细胞基因组学仪器(Fluidigm C1单细胞自动制备
系统,BioMark,和Illumina NextSeq 550测序系统)来评估细胞特异性基因组,
与VA使命高度相关的疾病的表观遗传和转录组变异。该测量仪表
将大大提高退伍军人事务部(VA)和非VA调查人员调查的机制,
单细胞水平的疾病进展。虽然在过去的几年里已经取得了巨大的进步,
十年来,我们在大量细胞群中处理和测序DNA和RNA的能力,直到最近,
在单细胞水平上理解基因组和转录组信息的显著变化
是有限的。例如,对基本生物过程的主要见解,如正常的
发展和肿瘤演变继发于单细胞的致癌潜力,只能从一个
详细了解基因组,表观基因组和转录变异在单细胞水平。此外,本发明还提供了一种方法,
某些致病细胞是如此罕见,以至于单细胞方法对于它们的鉴定变得至关重要,
特征化
我们的基因组学核心是一个正在进行的合作,以提高学术和行政
北港退伍军人事务医疗中心(NVAMC)及其附属的斯托尼布鲁克大学之间的关系
医学院(SBUSM)。这种新的仪器将被安置在NVAMC和这个战略位置
允许VA和SBUSM调查人员轻松访问仪器。这个核心的位置
鼓励北港的退伍军人事务部调查人员与斯托尼大学的同事进一步合作
布鲁克技术支持可通过基因组核心在收费服务的基础上,以支持VA
研究人员及其合作者。此外,我们还组建了一个生物信息学专家小组,
支持.许多退伍军人事务部的调查人员,包括Mallipattu博士、Lin博士、McKinnon博士、Rohatgi博士、米勒博士、Arvanian博士、Del
Poeta和Obeid,他们的研究得到了Merit Review Awards的支持,并将大大受益于
获得和利用这种仪器进行高通量单细胞基因组学。训练
核心的人员可以操作仪器并提供技术支持,我们已经制定了一个计划,
购买服务合同以维护仪器。
在用于高通量单细胞基因组学仪器的ShEEP应用中,我们还描述了
详细说明仪器的具体情况、需求的合理性,展示支持的技术专长
设备的使用情况、主要用户和次要用户的说明以及
仪器的使用。这种单细胞分析仪器的长期影响是,
提高影响力,并进一步我们目前资助的退伍军人管理局优秀评论奖。此外,取得的成果
将产生新的假设,并为未来的研究提供新的途径,
与退伍军人事务部使命高度相关的疾病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sandeep K Mallipattu其他文献
The Prevalence of Post-Acute Sequelae of COVID-19 in Solid Organ Transplant Recipients: Evaluation of Risk in the National COVID Cohort Collaborative (N3C).
实体器官移植受者中 COVID-19 急性后遗症的患病率:国家 COVID 队列协作组织 (N3C) 的风险评估。
- DOI:
10.1016/j.ajt.2024.06.001 - 发表时间:
2024 - 期刊:
- 影响因子:0
- 作者:
A. Vinson;Makayla Schissel;A. Anzalone;Ran Dai;E. French;A. Olex;Stephen B. Lee;Michael Ison;R. Mannon;A. Wilcox;Adam M. Lee;Alexis Graves;A. Anzalone;A. Manna;Amit Saha;A. Olex;Andrea Zhou;Andrew E. Williams;Andrew Southerland;A. Girvin;Anita Walden;Anjali A. Sharathkumar;B. Amor;Benjamin Bates;Brian Hendricks;Brijesh Patel;Caleb Alexander;Carolyn T Bramante;C. Ward‐Caviness;C. Madlock;Christine Suver;C. Chute;Christopher Dillon;Chunlei Wu;Clare Schmitt;Cliff Takemoto;D. Housman;D. Gabriel;David A. Eichmann;Diego Mazzotti;Don Brown;Eilis Boudreau;Elaine Hill;Elizabeth Zampino;E. Marti;Emily Pfaff;E. French;F. Koraishy;Federico Mariona;Fred Prior;G. Sokos;Greg Martin;H. Lehmann;Heidi Spratt;Hemalkumar Mehta;Hongfang Liu;Hythem Sidky;J. Hayanga;Jami D. Pincavitch;Jaylyn F. Clark;Jeremy Harper;Jessica Islam;Jin Ge;J. Gagnier;J. Saltz;J. Saltz;Johanna J. Loomba;Jon D. Buse;Jomol P Mathew;J. Rutter;J. McMurry;Justin Guinney;J. Starren;Kay Crowley;K. Bradwell;Kellie M. Walters;K. Wilkins;Kenneth R. Gersing;K. Cato;Kimberly Murray;K. Kostka;Lavance Northington;Lee A. Pyles;Leonie Misquitta;Lesley Cottrell;L. Portilla;Mariam Deacy;Mark Bissell;M. Clark;M. Emmett;M. Saltz;M. Palchuk;Melissa A. Haendel;Meredith Adams;Meredith Temple;Michael G. Kurilla;Michele Morris;N. Qureshi;Nasia Safdar;Nicole Garbarini;Noha Sharafeldin;O. Sadan;P. A. Francis;P. W. Burgoon;Peter Robinson;Philip R. O. Payne;Rafael Fuentes;R. Jawa;Rebecca Erwin;Rena C Patel;Richard A. Moffitt;R. Zhu;R. Kamaleswaran;R. Hurley;Robert T. Miller;S. Pyarajan;Sam G. Michael;Samuel Bozzette;Sandeep K Mallipattu;Satyanarayana Vedula;Scott A. Chapman;Shawn T O'Neil;Soko Setoguchi;Stephanie S. Hong;Steve Johnson;Tellen D. Bennett;Tiffany J. Callahan;Umit Topaloglu;Usman Sheikh;Valery Gordon;V. Subbian;Warren Kibbe;Wenndy Hernandez;Willarene P. Beasley;W. Cooper;W. Hillegass;X. Zhang - 通讯作者:
X. Zhang
Sandeep K Mallipattu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Sandeep K Mallipattu', 18)}}的其他基金
Single-cell Cyclic Multiplex in Situ Tagging to Advance Kidney Research
单细胞循环多重原位标记促进肾脏研究
- 批准号:
10790122 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Small Molecule KLF15 Agonists for Kidney Disease
治疗肾脏疾病的小分子 KLF15 激动剂
- 批准号:
10553107 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Small Molecule KLF15 Agonists for Kidney Disease
治疗肾脏疾病的小分子 KLF15 激动剂
- 批准号:
10117332 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Small Molecule KLF15 Agonists for Kidney Disease
治疗肾脏疾病的小分子 KLF15 激动剂
- 批准号:
10359057 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Transcriptional control of mitochondrial function by KLF6 in diabetic kidney disease
KLF6 在糖尿病肾病中对线粒体功能的转录控制
- 批准号:
10400042 - 财政年份:2017
- 资助金额:
-- - 项目类别:
Transcriptional control of mitochondrial function by KLF6 in diabetic kidney disease
KLF6 在糖尿病肾病中对线粒体功能的转录控制
- 批准号:
9918361 - 财政年份:2017
- 资助金额:
-- - 项目类别:
Transcriptional control of mitochondrial function by KLF6 in diabetic kidney disease
KLF6 在糖尿病肾病中对线粒体功能的转录控制
- 批准号:
9286505 - 财政年份:2017
- 资助金额:
-- - 项目类别:
The Role of KLF15 as a transcriptional regulator of podocyte differentiation
KLF15 作为足细胞分化转录调节因子的作用
- 批准号:
8750137 - 财政年份:2014
- 资助金额:
-- - 项目类别:
The Role of KLF15 as a transcriptional regulator of podocyte differentiation
KLF15 作为足细胞分化转录调节因子的作用
- 批准号:
8916713 - 财政年份:2014
- 资助金额:
-- - 项目类别:
相似海外基金
Nitrous Oxide Management in a Novel Biological Process
新型生物过程中的一氧化二氮管理
- 批准号:
2789227 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Studentship
Dynamic regulation of RNA modification and biological process
RNA修饰和生物过程的动态调控
- 批准号:
18H05272 - 财政年份:2018
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (S)
Micro-Scale Biological Process Automation: Modelling, Sensing and Control
微尺度生物过程自动化:建模、传感和控制
- 批准号:
42116-2013 - 财政年份:2017
- 资助金额:
-- - 项目类别:
Discovery Grants Program - Individual
Micro-Scale Biological Process Automation: Modelling, Sensing and Control
微尺度生物过程自动化:建模、传感和控制
- 批准号:
42116-2013 - 财政年份:2016
- 资助金额:
-- - 项目类别:
Discovery Grants Program - Individual
Organizing the Waterloo Biofilter biological process for treating wastewater concentrated by extreme water conservation plumbing
组织滑铁卢生物过滤器生物工艺处理通过极端节水管道浓缩的废水
- 批准号:
479764-2015 - 财政年份:2015
- 资助金额:
-- - 项目类别:
Engage Grants Program
Micro-Scale Biological Process Automation: Modelling, Sensing and Control
微尺度生物过程自动化:建模、传感和控制
- 批准号:
42116-2013 - 财政年份:2015
- 资助金额:
-- - 项目类别:
Discovery Grants Program - Individual
Development of Biological Process for VOC treatment
VOC处理生物工艺的开发
- 批准号:
476672-2014 - 财政年份:2015
- 资助金额:
-- - 项目类别:
Experience Awards (previously Industrial Undergraduate Student Research Awards)
Micro-Scale Biological Process Automation: Modelling, Sensing and Control
微尺度生物过程自动化:建模、传感和控制
- 批准号:
42116-2013 - 财政年份:2014
- 资助金额:
-- - 项目类别:
Discovery Grants Program - Individual
Optimization of a biological process treating winery wastewater: anaerobic digestion integrated with Waterloo biofilter
处理酿酒厂废水的生物工艺优化:厌氧消化与滑铁卢生物过滤器集成
- 批准号:
463193-2014 - 财政年份:2014
- 资助金额:
-- - 项目类别:
Engage Grants Program
Micro-Scale Biological Process Automation: Modelling, Sensing and Control
微尺度生物过程自动化:建模、传感和控制
- 批准号:
42116-2013 - 财政年份:2013
- 资助金额:
-- - 项目类别:
Discovery Grants Program - Individual